Healthcare infrastructure development and increased funding are likely to drive demand for pharmerging.Wilmington, Delaware, ...

GEORGIA AVENUE, WA, UNITED STATES, October 17, 2024 /EINPresswire / -- The latest release from Vantage <a target=_blank href= ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of ...

InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

Automated insulin delivery systems not only improved glycemic endpoints but also alleviated disease burden and enhanced ...

Pharmac's decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live ...

To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...

People with Type 1 diabetes can connect their Dexcom blood-glucose sensor — an FDA-approved medical device — directly to ...

DexCom, Inc. (NASDAQ:DXCM) has also consistently beat EPS estimates in the last 4 quarters. The stock has received an average ...